Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Vaccines

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...

Vaccinations

Vaccinations

Vaccine Production

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

Cross-reactivity

Cross-reactivity

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Individual- and Neighborhood-Level Predictors of HIV Care Continuum Progression: Clark County, Nevada.

Open forum infectious diseases·2025

Same author

Ventral hernia repair in India: a Delphi consensus.

Hernia : the journal of hernias and abdominal wall surgery·2024

Same author

Evaluation of the impact of continuous Kangaroo Mother Care (KMC) initiated immediately after birth compared to KMC initiated after stabilization in newborns with birth weight 1.0 to < 1.8 kg on neurodevelopmental outcomes: Protocol for a follow-up study.

Trials·2023

Same author

Comments on Article: Agarwal S, Singh SN, Kumar R et al. Vitamin D: A Modulator of Allergic Rhinitis. Indian J Otolaryngol Head Neck Surg 71(Suppl 3):2225-2230.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India·2022

Same author

Reply to comments on small bowel knots.

Annals of the Royal College of Surgeons of England·2022

Same author

Corrigendum to "Polyglutamic acid-based nanocomposites as efficient non-viral gene carriers in vitro and in vivo" [Eur. J. Pharm. Biopharm. 79(3) (2011) 473-484].

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2022

Search research articles

Related Experiment Video

Updated: Jul 14, 2026

Transient Expression in Red Beet of a Biopharmaceutical Candidate Vaccine for Type-1 Diabetes

Transient Expression in Red Beet of a Biopharmaceutical Candidate Vaccine for Type-1 Diabetes

Published on: March 19, 2019

Edible vaccines: current status and future.

P Lal¹, V G Ramachandran, R Goyal

¹Department of Microbiology, University College of Medical Sciences, Guru Teg Bahadur Hospital, New Delhi - 110 095, India.

Indian Journal of Medical Microbiology

|June 22, 2007

Summary

Edible vaccines, using genetically modified plants to produce therapeutic proteins, offer a promising, cost-effective solution for disease prevention, particularly in developing nations. This innovative approach is expanding beyond infectious diseases to other health applications.

More Related Videos

Synthesis and Characterization of mRNA-Loaded Poly(Beta Aminoesters) Nanoparticles for Vaccination Purposes

Synthesis and Characterization of mRNA-Loaded Poly(Beta Aminoesters) Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

Related Experiment Videos

Last Updated: Jul 14, 2026

Transient Expression in Red Beet of a Biopharmaceutical Candidate Vaccine for Type-1 Diabetes

Transient Expression in Red Beet of a Biopharmaceutical Candidate Vaccine for Type-1 Diabetes

Published on: March 19, 2019

Synthesis and Characterization of mRNA-Loaded Poly(Beta Aminoesters) Nanoparticles for Vaccination Purposes

Synthesis and Characterization of mRNA-Loaded Poly(Beta Aminoesters) Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

Area of Science:

Biotechnology
Vaccinology
Plant Molecular Biology

Background:

Edible vaccines represent a novel vaccine delivery system utilizing genetically modified plants to produce antigens.
This technology offers advantages such as low cost, ease of administration, and stability, making it suitable for global health initiatives.
Initially conceptualized for infectious diseases, edible vaccines now show potential for treating autoimmune disorders, cancer, and other conditions.

Purpose of the Study:

To review the current status and future prospects of edible vaccine technology.
To highlight the potential benefits and applications of edible vaccines, especially in resource-limited settings.
To discuss the challenges and opportunities associated with the development and implementation of edible vaccines.

Main Methods:

Review of existing literature on edible vaccine development and applications.
Analysis of the scientific, regulatory, and societal factors influencing edible vaccine technology.
Discussion of the genetic engineering techniques used to produce vaccine components in plants.

Main Results:

Edible vaccines have evolved from a concept to a tangible reality with diverse applications.
Transgenic crops are increasingly accepted, paving the way for edible vaccine integration.
Significant progress has been made, overcoming initial technical and scientific hurdles.

Conclusions:

Edible vaccines present a viable, cost-effective, and accessible preventive health strategy.
Overcoming regulatory and societal challenges is crucial for the widespread adoption of edible vaccines.
The future of edible vaccines is promising, with ongoing research expanding their therapeutic potential.